A LinkedIn post from Clarium describes the company’s participation in the SMI Spring Forum in Frisco, Texas, where Clarium’s Marcelo Fracchia and Cleveland Clinic’s Sarah Charai discussed a collaboration. The session reportedly focused on reducing variability in procedural areas through co-development of a preference card capability rather than primarily targeting direct cost savings.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
According to the post, the initiative emphasized establishing a consistent methodology by steering utilization toward the most used suppliers, with clinical leaders creating “gold standard” procedure cards to ensure engagement. Technology is portrayed as an enabler by making reviews documented and transparent, while the collaboration has standardized 170 procedures and reduced preference cards from 55,000 to about 17,000, implying potential operational efficiency gains.
For investors, the described results suggest Clarium is positioning its solutions as tools for standardization and process optimization within large health systems such as Cleveland Clinic. If replicable across additional clients, this type of workflow and data-driven capability could support recurring software or services revenue, deepen strategic partnerships, and enhance Clarium’s competitive standing in the healthcare supply chain and procedural management segment.
The post also notes that the initial connection with Cleveland Clinic originated at a prior SMI event, highlighting industry forums as a business development channel. This dynamic may indicate that Clarium’s growth strategy leans on ecosystem engagement and co-development with marquee providers, which could help validate its offerings but may also lengthen sales cycles and concentrate exposure to large enterprise customers.

